Paydirt
CJ
Insider

Charles F Wagner Jr

EVP, CO & FO · Vertex Pharmaceuticals

Charles F Wagner Jr (EVP, CO & FO) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Vertex Pharmaceuticals Incorporated (VRTX). The largest single filing was $6.4M of VRTX (14,000 sh across 2 lots, as filed), executed Dec 3 2025. Data as of Nov 8 2026.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$10.8M
shares × price, as filed
Last traded
Jan 6
Filed Jan 8

Median ADV $756.7M across their filed names

Open performance→
Volume by month
$6.4M$3.2M$0Dec 2024Jun 2025Dec 2025Jun 2026Mar 2025 · sells $1.6MDec 2025 · sells $6.4MJan 2026 · sells $4.4M
Buys $0 Sells $12.4M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names
VRTX Vertex Pharmaceuticals Incorporated VRTX · 0 buys · 4 sells 4 filings
Recent filings
VRTXSALE Vertex Pharmaceuticals Incorporated View filing → $4.4M
9,532 sh × $461.00
Exec Jan 6
Filed Jan 8 · 5:30 PM ET
VRTXSALE Vertex Pharmaceuticals Incorporated View filing → $6.4M
14,000 sh across 2 lots
Exec Dec 3 2025
Filed Dec 5 2025 · 5:30 PM ET
VRTXSALE Vertex Pharmaceuticals Incorporated View filing → $1.6M
3,298 sh × $500.00
Exec Mar 10 2025
Filed Mar 12 2025 · 5:30 PM ET
VRTXSALE Vertex Pharmaceuticals Incorporated View filing → $1.6M
3,000 sh × $518.27
Exec Nov 11 2024
Filed Nov 13 2024 · 5:30 PM ET